Characterization and Analysis of the Skin Microbiota in Rosacea: A Case–Control Study

Barbara M. Rainer, Katherine G. Thompson, Corina Antonescu, Liliana Florea, Emmanuel F. Mongodin, Jonathan Bui, Alexander H. Fischer, Helena B. Pasieka, Luis A. Garza, Sewon Kang, Anna L. Chien

Research output: Contribution to journalArticle

Abstract

Background: The efficacy of antibiotics in rosacea treatment suggests a role for microorganisms in its pathophysiology. Growing concern over the adverse effects of antibiotic use presents a need for targeted antimicrobial treatment in rosacea. Objective: We performed a case–control study to investigate the skin microbiota in patients with rosacea compared to controls matched by age, sex, and race. Methods: Nineteen participants with rosacea, erythematotelangiectatic, papulopustular, or both, were matched to 19 rosacea-free controls. DNA was extracted from skin swabs of the nose and bilateral cheeks of participants. Sequencing of the V3V4 region of the bacterial 16S ribosomal RNA gene was performed using Illumina MiSeq and analyzed using QIIME/MetaStats 2.0 software. Results: Compared with controls, skin microbiota in erythematotelangiectatic rosacea was depleted in Roseomonas mucosa (p = 0.004). Papulopustular rosacea was enriched in Campylobacter ureolyticus (p = 0.001), Corynebacterium kroppenstedtii (p = 0.008), and the oral flora Prevotella intermedia (p = 0.001). The highest relative abundance of C. kroppenstedtii was observed in patients with both erythematotelangiectatic and papulopustular rosacea (19.2%), followed by papulopustular (5.06%) and erythematotelangiectatic (1.21%) rosacea. C. kroppenstedtii was also associated with more extensive disease, with the highest relative abundance in rosacea affecting both the cheeks and nose (2.82%), followed by rosacea sparing the nose (1.93%), and controls (0.19%). Conclusions: The skin microbiota in individuals with rosacea displays changes from that of healthy skin, suggesting that further studies examining a potential role for the skin microbiota in the pathophysiology of rosacea may be warranted.

Original languageEnglish (US)
JournalAmerican Journal of Clinical Dermatology
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Rosacea
Microbiota
Skin
Nose
Cheek
Methylobacteriaceae
Prevotella intermedia
16S Ribosomal RNA
Anti-Bacterial Agents
Corynebacterium
Campylobacter

ASJC Scopus subject areas

  • Dermatology

Cite this

Characterization and Analysis of the Skin Microbiota in Rosacea : A Case–Control Study. / Rainer, Barbara M.; Thompson, Katherine G.; Antonescu, Corina; Florea, Liliana; Mongodin, Emmanuel F.; Bui, Jonathan; Fischer, Alexander H.; Pasieka, Helena B.; Garza, Luis A.; Kang, Sewon; Chien, Anna L.

In: American Journal of Clinical Dermatology, 01.01.2019.

Research output: Contribution to journalArticle

Rainer, Barbara M. ; Thompson, Katherine G. ; Antonescu, Corina ; Florea, Liliana ; Mongodin, Emmanuel F. ; Bui, Jonathan ; Fischer, Alexander H. ; Pasieka, Helena B. ; Garza, Luis A. ; Kang, Sewon ; Chien, Anna L. / Characterization and Analysis of the Skin Microbiota in Rosacea : A Case–Control Study. In: American Journal of Clinical Dermatology. 2019.
@article{0d8e22b3d6ef44fdb7003bfaed26c2e0,
title = "Characterization and Analysis of the Skin Microbiota in Rosacea: A Case–Control Study",
abstract = "Background: The efficacy of antibiotics in rosacea treatment suggests a role for microorganisms in its pathophysiology. Growing concern over the adverse effects of antibiotic use presents a need for targeted antimicrobial treatment in rosacea. Objective: We performed a case–control study to investigate the skin microbiota in patients with rosacea compared to controls matched by age, sex, and race. Methods: Nineteen participants with rosacea, erythematotelangiectatic, papulopustular, or both, were matched to 19 rosacea-free controls. DNA was extracted from skin swabs of the nose and bilateral cheeks of participants. Sequencing of the V3V4 region of the bacterial 16S ribosomal RNA gene was performed using Illumina MiSeq and analyzed using QIIME/MetaStats 2.0 software. Results: Compared with controls, skin microbiota in erythematotelangiectatic rosacea was depleted in Roseomonas mucosa (p = 0.004). Papulopustular rosacea was enriched in Campylobacter ureolyticus (p = 0.001), Corynebacterium kroppenstedtii (p = 0.008), and the oral flora Prevotella intermedia (p = 0.001). The highest relative abundance of C. kroppenstedtii was observed in patients with both erythematotelangiectatic and papulopustular rosacea (19.2{\%}), followed by papulopustular (5.06{\%}) and erythematotelangiectatic (1.21{\%}) rosacea. C. kroppenstedtii was also associated with more extensive disease, with the highest relative abundance in rosacea affecting both the cheeks and nose (2.82{\%}), followed by rosacea sparing the nose (1.93{\%}), and controls (0.19{\%}). Conclusions: The skin microbiota in individuals with rosacea displays changes from that of healthy skin, suggesting that further studies examining a potential role for the skin microbiota in the pathophysiology of rosacea may be warranted.",
author = "Rainer, {Barbara M.} and Thompson, {Katherine G.} and Corina Antonescu and Liliana Florea and Mongodin, {Emmanuel F.} and Jonathan Bui and Fischer, {Alexander H.} and Pasieka, {Helena B.} and Garza, {Luis A.} and Sewon Kang and Chien, {Anna L.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s40257-019-00471-5",
language = "English (US)",
journal = "American Journal of Clinical Dermatology",
issn = "1175-0561",
publisher = "Adis International Ltd",

}

TY - JOUR

T1 - Characterization and Analysis of the Skin Microbiota in Rosacea

T2 - A Case–Control Study

AU - Rainer, Barbara M.

AU - Thompson, Katherine G.

AU - Antonescu, Corina

AU - Florea, Liliana

AU - Mongodin, Emmanuel F.

AU - Bui, Jonathan

AU - Fischer, Alexander H.

AU - Pasieka, Helena B.

AU - Garza, Luis A.

AU - Kang, Sewon

AU - Chien, Anna L.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: The efficacy of antibiotics in rosacea treatment suggests a role for microorganisms in its pathophysiology. Growing concern over the adverse effects of antibiotic use presents a need for targeted antimicrobial treatment in rosacea. Objective: We performed a case–control study to investigate the skin microbiota in patients with rosacea compared to controls matched by age, sex, and race. Methods: Nineteen participants with rosacea, erythematotelangiectatic, papulopustular, or both, were matched to 19 rosacea-free controls. DNA was extracted from skin swabs of the nose and bilateral cheeks of participants. Sequencing of the V3V4 region of the bacterial 16S ribosomal RNA gene was performed using Illumina MiSeq and analyzed using QIIME/MetaStats 2.0 software. Results: Compared with controls, skin microbiota in erythematotelangiectatic rosacea was depleted in Roseomonas mucosa (p = 0.004). Papulopustular rosacea was enriched in Campylobacter ureolyticus (p = 0.001), Corynebacterium kroppenstedtii (p = 0.008), and the oral flora Prevotella intermedia (p = 0.001). The highest relative abundance of C. kroppenstedtii was observed in patients with both erythematotelangiectatic and papulopustular rosacea (19.2%), followed by papulopustular (5.06%) and erythematotelangiectatic (1.21%) rosacea. C. kroppenstedtii was also associated with more extensive disease, with the highest relative abundance in rosacea affecting both the cheeks and nose (2.82%), followed by rosacea sparing the nose (1.93%), and controls (0.19%). Conclusions: The skin microbiota in individuals with rosacea displays changes from that of healthy skin, suggesting that further studies examining a potential role for the skin microbiota in the pathophysiology of rosacea may be warranted.

AB - Background: The efficacy of antibiotics in rosacea treatment suggests a role for microorganisms in its pathophysiology. Growing concern over the adverse effects of antibiotic use presents a need for targeted antimicrobial treatment in rosacea. Objective: We performed a case–control study to investigate the skin microbiota in patients with rosacea compared to controls matched by age, sex, and race. Methods: Nineteen participants with rosacea, erythematotelangiectatic, papulopustular, or both, were matched to 19 rosacea-free controls. DNA was extracted from skin swabs of the nose and bilateral cheeks of participants. Sequencing of the V3V4 region of the bacterial 16S ribosomal RNA gene was performed using Illumina MiSeq and analyzed using QIIME/MetaStats 2.0 software. Results: Compared with controls, skin microbiota in erythematotelangiectatic rosacea was depleted in Roseomonas mucosa (p = 0.004). Papulopustular rosacea was enriched in Campylobacter ureolyticus (p = 0.001), Corynebacterium kroppenstedtii (p = 0.008), and the oral flora Prevotella intermedia (p = 0.001). The highest relative abundance of C. kroppenstedtii was observed in patients with both erythematotelangiectatic and papulopustular rosacea (19.2%), followed by papulopustular (5.06%) and erythematotelangiectatic (1.21%) rosacea. C. kroppenstedtii was also associated with more extensive disease, with the highest relative abundance in rosacea affecting both the cheeks and nose (2.82%), followed by rosacea sparing the nose (1.93%), and controls (0.19%). Conclusions: The skin microbiota in individuals with rosacea displays changes from that of healthy skin, suggesting that further studies examining a potential role for the skin microbiota in the pathophysiology of rosacea may be warranted.

UR - http://www.scopus.com/inward/record.url?scp=85073786390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073786390&partnerID=8YFLogxK

U2 - 10.1007/s40257-019-00471-5

DO - 10.1007/s40257-019-00471-5

M3 - Article

C2 - 31502207

AN - SCOPUS:85073786390

JO - American Journal of Clinical Dermatology

JF - American Journal of Clinical Dermatology

SN - 1175-0561

ER -